Inovio Pharmaceuticals, Inc.
VACCINES AGAINST CORONAVIRUS AND METHODS OF USE
Last updated:
Abstract:
Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen, SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune responses and protecting against or treating a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection in a subject.
Status:
Application
Type:
Utility
Filling date:
25 Feb 2021
Issue date:
2 Sep 2021